Skip to content
PubMed This is a summary of 9 peer-reviewed journal articles Updated
Pulmonology

Asthma Types, Biology, and Phenotypes

At a Glance

Asthma is not a single disease, but a group of conditions with different underlying biological causes. Identifying your specific asthma "type" or phenotype—such as T2-high, T2-low, or cough-variant asthma—allows your doctor to match you with targeted, highly effective treatments.

The term “asthma” is actually an umbrella for several different conditions that look similar but have very different biological “engines” driving them. Doctors call these variations phenotypes (what you see on the outside, like a cough) and endotypes (the specific immune pathway causing the problem on the inside) [1]. Understanding your specific type is the key to moving from trial-and-error to targeted, precision medicine.

The Great Divide: T2-High vs. T2-Low

The most important distinction in modern asthma care is whether your inflammation is driven by the Type 2 (T2) immune pathway.

  • T2-High Asthma: This is the most common form. Your immune system is in “overdrive,” producing high levels of eosinophils (a type of white blood cell) and IgE (an antibody related to allergies) [2].
    • How it’s found: Doctors look for a blood eosinophil count (typically over 150–300 cells/µL) or high IgE levels [3].
    • Why it matters: T2-high asthma usually responds very well to inhaled corticosteroids. If it’s severe, it can be treated with “biologics”—highly targeted injections that switch off specific T2 molecules [1].
  • T2-Low Asthma: This type is not driven by the typical allergic/eosinophilic pathway. It is often seen in people who develop asthma later in life, people who smoke, or those with obesity [4].
    • Why it matters: Because it isn’t driven by eosinophils, it may not respond as well to standard steroid inhalers, requiring different strategies to manage symptoms [4].

Specific Asthma Subtypes

Beyond the immune “engine,” your asthma may fall into a specific clinical category based on how it presents:

Cough-Variant Asthma (CVA)

In Cough-Variant Asthma, the “classic” wheezing and shortness of breath are absent. Instead, the only symptom is a persistent, dry, hacking cough [5].

  • The Trap: Because there is no wheeze, it is often misdiagnosed as bronchitis or “post-nasal drip.”
  • Confirmation: It is often diagnosed using a FeNO test (measuring nitric oxide in your breath) or by seeing if the cough disappears when using asthma medication [6][7].

Occupational Asthma

This type is caused or made worse by triggers in the workplace (like chemicals, dust, or fumes). It is generally split into two types:

  1. Sensitizer-Induced: You develop an allergy to a specific substance at work over time. Symptoms may not appear immediately but get worse with every exposure [8].
  2. Irritant-Induced: This is caused by a single, high-dose exposure to a “lung irritant” (like a chemical spill or smoke) that causes immediate, long-term airway sensitivity [9].

Why Your “Numbers” Matter

To identify your type, your doctor may use several “biomarkers”:

  • Blood Eosinophils: A high count points toward T2-high/eosinophilic asthma [3].
  • Total IgE: High levels suggest an allergic component is driving your flares [2].
  • FeNO (Fractional Exhaled Nitric Oxide): This breath test measures active T2 inflammation in your airways right now [6].

Knowing these numbers helps your doctor “match” the right medication to your specific biological engine, ensuring you aren’t taking more medicine than you need—or the wrong kind altogether.

Common questions in this guide

What is the difference between T2-high and T2-low asthma?
T2-high asthma is driven by an overactive immune system producing high levels of allergic markers like eosinophils and IgE. It typically responds well to inhaled steroids. T2-low asthma is not driven by these allergic pathways and may require different management strategies.
What is cough-variant asthma?
Cough-variant asthma is a subtype where the only symptom is a persistent, dry, hacking cough. Because it lacks the classic wheezing or shortness of breath, it is frequently mistaken for conditions like bronchitis or post-nasal drip.
How do doctors determine my specific asthma type?
Doctors use specific biomarker tests to identify your biological asthma engine. They may test your blood for eosinophil counts and total IgE levels, or use a breath test called FeNO to measure active inflammation in your airways.
Can my job cause asthma?
Yes, occupational asthma is caused or worsened by workplace triggers like dust, fumes, or chemicals. You can develop it gradually over time as an allergy to a specific substance, or immediately after a single high-dose exposure to an irritant.
Will knowing my asthma type change my treatment options?
Yes, identifying your exact type allows your doctor to prescribe targeted therapy. For instance, if you have severe T2-high asthma, you might qualify for specialized biologic injections that switch off the specific molecules causing your inflammation.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my blood work, do I have 'T2-high' or 'T2-low' asthma, and how does that change my medication options?
  2. 2.What was my blood eosinophil count and IgE level, and are they high enough to qualify me for specialized 'biologic' treatments?
  3. 3.Since my main symptom is a cough, could I have Cough-Variant Asthma, and should we do a FeNO test to confirm?
  4. 4.If my symptoms are worse at work, could this be sensitizer-induced or irritant-induced occupational asthma?
  5. 5.Will my type of asthma respond better to traditional steroids or do we need to consider different anti-inflammatory approaches?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (9)
  1. 1

    Asthma phenotypes and endotypes.

    Ricciardolo FL, Bertolini F, Carriero V, Sprio AE

    Minerva medica 2021; (112(5)):547-563 doi:10.23736/S0026-4806.21.07498-X.

    PMID: 33969960
  2. 2

    Biological therapies for eosinophilic asthma.

    Patel SS, Casale TB, Cardet JC

    Expert opinion on biological therapy 2018; (18(7)):747-754 doi:10.1080/14712598.2018.1492540.

    PMID: 29938543
  3. 3

    Relapsing Eosinophilia in a Severe Allergic Asthma Patient on Biological Therapy.

    Raduna O, Oprescu B, Mihaicuta S, Frent S

    Journal of clinical medicine 2024; (13(12)) doi:10.3390/jcm13123402.

    PMID: 38929930
  4. 4

    Advances in non-type 2 severe asthma: from molecular insights to novel treatment strategies.

    Liu T, Woodruff PG, Zhou X

    The European respiratory journal 2024; (64(2)) doi:10.1183/13993003.00826-2023.

    PMID: 38697650
  5. 5

    Cough-Variant Asthma: A Review of Clinical Characteristics, Diagnosis, and Pathophysiology.

    Cox JK, Lockey R, Cardet JC

    The journal of allergy and clinical immunology. In practice 2025; (13(3)):490-498 doi:10.1016/j.jaip.2024.11.005.

    PMID: 39557293
  6. 6

    Values of fractional exhaled nitric oxide for cough-variant asthma in children with chronic cough.

    Zhou J, Zhao X, Zhang X, et al.

    Journal of thoracic disease 2018; (10(12)):6616-6623 doi:10.21037/jtd.2018.11.137.

    PMID: 30746207
  7. 7

    Retrospective Analysis of the Starting Dose of Combined ICS/LABA for Cough-variant Asthma and Cough-predominant Asthma.

    Nakajima T, Nagano T, Nishimura Y

    In vivo (Athens, Greece) 2022; (36(2)):949-953 doi:10.21873/invivo.12785.

    PMID: 35241554
  8. 8

    Occupational asthma.

    Cormier M, Lemière C

    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2020; (24(1)):8-21 doi:10.5588/ijtld.19.0301.

    PMID: 32005302
  9. 9

    Work-related asthma: A position paper from the Thoracic Society of Australia and New Zealand and the National Asthma Council Australia.

    Hoy R, Burdon J, Chen L, et al.

    Respirology (Carlton, Vic.) 2020; (25(11)):1183-1192 doi:10.1111/resp.13951.

    PMID: 33020986

This page is for informational purposes only and does not replace professional medical advice. Always consult your pulmonologist or allergist to determine your specific asthma type and the best treatment approach for you.

Get notified when new evidence is published on asthma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.